Skip to main content

Advertisement

SpringerLink
Log in

Effect of Licofelone—A Dual COX/5-LOX Inhibitor in Intracerebroventricular Streptozotocin-Induced Behavioral and Biochemical Abnormalities in Rats

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The present study was designed to investigate the effect of licofelone—a dual cyclooxygenase/5-lipoxygenase (COX/5-LOX) inhibitor in intracerebroventricular streptozotocin (ICV-STZ)-induced cognitive deficit and biochemical abnormalities in rats. ICV-STZ is a widely used model of sporadic Alzheimer’s disease. In this study, STZ was administered intracerebroventricular (ICV)-bilaterally 3 mg/kg in rats. The STZ-injected rats were treated with different doses of licofelone (2.5, 5, and 10 mg/kg, p.o.) for 21 days. Cognitive functions were assessed by using Morris water maze and passive avoidance task. Levels of malondialdehyde (MDA), nitrite, reduced glutathione (GSH), and acetylcholinesterase (AChE) activity were determined to check oxidative stress and cholinergic function. Cytokine levels (IL-1β and TNF-α) were also determined as markers of neuroinflammation. Administration of STZ caused a significant increase in AChE activity and cognitive dysfunction. Increased oxidative stress and the proinflammatory cytokine levels were also observed following STZ administration in rats. Licofelone treatment attenuated STZ-induced cholinergic hypofunction and cognitive deficit in rats. In addition, licofelone attenuated STZ-induced oxidative stress and elevated cytokine levels. The cognitive enhancement following licofelone administration in STZ rats may be due to its ability to restore cholinergic functions or its antioxidant activity. These observed results suggest the therapeutic potential of dual COX/5-LOX inhibitors in neurodegenerative disorders associated with oxidative stress and cognitive impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Andreasson KI, Savonenko A, Vidensky S, Goellner JJ, Zhang Y, Shaffer A et al (2001) Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 21:8198–8209

    CAS  PubMed  Google Scholar 

  • Baran H, Vass K, Lassmann H, Hornykiewicz O (1994) The cyclooxygenase and lipoxygenase inhibitor BW755C protects rats against kainic acid-induced seizures and neurotoxicity. Brain Res 646:201–206

    Article  CAS  PubMed  Google Scholar 

  • Barker GRI, Warburton CE (2009) Critical role of the cholinergic system for object-in-place associative recognition memory. Learn Mem 16:8–11

    Article  PubMed Central  PubMed  Google Scholar 

  • Bishnoi M, Bosgraaf CA, Abooj M, Zhong L, Premkumar LS (2011) Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1 (TRPV1) and inflammatory mediators. Mol Pain 7:1–11

    Article  Google Scholar 

  • Bruce-Keller AJ, Li YJ, Lovell MA, Kraemer PJ, Gary DS, Brown RR et al (1998) 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 57:257–267

    Article  CAS  PubMed  Google Scholar 

  • Butcher LL, Woolf NJ, Scheibel AB, Weschsler AF (1986) Central cholinergic systems: synopsis of anatomy and overview of physiology and pathology. The biological substrate of Alzheimer’s diseases. Academic, New York, pp 73–86

    Google Scholar 

  • Calanni F, Laufer S (2003) Biochemistry and mediators of inflammation. In: Laufer S, Gay S, Brune K (eds) Inflammation and rheumatic diseases. The molecular basis of novel therapies. Georg Thieme Verlag, Stuttgart, pp 15–57

    Google Scholar 

  • Candelario-Jalil E, Alvarez D, Merino N, Leon OS (2003) Delayed treatment with nimesulide reduces measures of oxidative stress following global ischemic brain injury in gerbils. Neurosci Res 47:245–253

    Article  CAS  PubMed  Google Scholar 

  • Consilvio C, Vincent AM, Feldman EL (2004) Neuroinflammation, COX-2, and ALS—a dual role? Exp Neurol 187:1–10

    Article  CAS  PubMed  Google Scholar 

  • Deshmukh R, Sharma V, Mehan S, Sharma N, Bedi KL (2009) Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine—a PDE1 inhibitor. Eur J Pharmacol 620:49–56

    Article  CAS  PubMed  Google Scholar 

  • Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SSV (2011) Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic Alzheimer’s disease in rats. J Mol Neurosci 46(1):223–235

    Article  PubMed  Google Scholar 

  • Di Bona D, Plaia A, Vasto S, Cavallone L, Lescai F, Franceschi C et al (2008) Association between the interleukin-1β polymorphisms and Alzheimer’s disease: a systematic review and meta-analysis. Brain Res Rev 59:155–163

    Article  PubMed  Google Scholar 

  • Di Bona D, Vasto S, Capurso C, Christiansen L, Deiana L, Franceschi C et al (2009) Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res Rev 8:36–42

    Article  PubMed  Google Scholar 

  • Dulin JN, Karoly ED, Wang Y, Strobel HW, Grill RJ (2013) Licofelone modulates neuroinflammation and attenuates mechanical hypersensitivity in the chronic phase of spinal cord injury. J Neurosci 33:652–664

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE et al (2008) Microglia, amyloid, and cognition in Alzheimer’s disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32:412–419

    Article  CAS  PubMed  Google Scholar 

  • Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77

    Article  CAS  PubMed  Google Scholar 

  • Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95

    Article  CAS  PubMed  Google Scholar 

  • Everitt BJ, Robbins TW (1997) Central cholinergic systems and cognition. Annu Rev Psychol 48:649–684

    Article  CAS  PubMed  Google Scholar 

  • Fillit H, Ding WH, Buee L, Kalman J, Altstiel L, Lawlor B et al (1991) Elevated circulating tumor necrosis factor levels in Alzheimer’s disease. Neurosci Lett 129:318–320

    Article  CAS  PubMed  Google Scholar 

  • Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Pratico D (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer’s disease. FASEB J 22:1169–1178

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Gotz J, Gotz NN (2009) Animal models for Alzheimer’s disease and frontotemporal dementia: a perspective. ASN Neuro 1:251–264

    Article  CAS  Google Scholar 

  • Green LC, Wagner DA, Glgowski J, Skipper PL, Wishnok JS, Tannebaum SR (1982) Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Ann Biochem Exp Med 126:131–135

    Article  CAS  Google Scholar 

  • Griffin WST, Stanley LC, Ling C, White L, Macleod V, Perrot LJ (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86:7611–7615

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Haense C, Kalbe E, Herholz K, Hohmann C, Neumaier B, Krais R, Heiss WD (2012) Cholinergic system function and cognition in mild cognitive impairment. Neurobiol Aging 33:867–877

    Article  CAS  PubMed  Google Scholar 

  • Hein AM, O’Banion MK (2009) Neuroinflammation and memory: the role of prostaglandins. Mol Neurobiol 40:15–32

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Hein AM, Stutzman DL, Bland ST, Barrientos RM, Watkins LR, Rudy JW et al (2007) Prostaglandins are necessary and sufficient to induce contextual fear learning impairments after interleukin-1 beta injections into the dorsal hippocampus. Neuroscience 150:754–763

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ishrat T, Hoda MN, Khan MB, Yousuf S, Ahmad M, Khan MM et al (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer’s type (SDAT). Eur Neuropsychopharmacol 21:1–12

    Google Scholar 

  • Kalonia H, Kumar P, Kumar A (2011) Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations. Prog Neuropsychopharmacol Biol Psychiatry 35:607–615

    Article  CAS  PubMed  Google Scholar 

  • Klegeris A, McGeer PL (2002) Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging 23:787–794

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Seghal N, Padi SSV, Naidu PS (2006a) Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicines induced dysfunction and oxidative stress in rats. Eur J Pharmacol 551:58–66

    Article  CAS  PubMed  Google Scholar 

  • Kumar P, Padi SSV, Naidu PS, Kumar A (2006b) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17:485–492

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Vashist A, Kumar P, Kalonia H, Mishra J (2012) Potential role of licofelone, minocycline and their combination against chronic fatigue stress induced behavioral, biochemical and mitochondrial alterations in mice. Pharmacol Rep 64:1105–1115

    Article  CAS  PubMed  Google Scholar 

  • Lammers CH, Schweitzer P, Facchinetti P, Arrang JM, Madamba SG, Siggins GR et al (1996) Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem 66:147–152

    Article  CAS  PubMed  Google Scholar 

  • Lima IVA, Bastos LFS, Filho ML, Fiebich BL, Oliveira ACP (2012) Role of prostaglandins in neuroinflammatory and neurodegenerative diseases. Mediat Inflamm 2012:1–13

    Article  Google Scholar 

  • Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B et al (2001) Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 100:8526–8531

    Article  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • Madrigal JLM, Moro MA, Lizasoain I, Lorenzo P, Fernandez AP, Rodrigo J et al (2003) Induction of cyclooxygenase-2 accounts for restraint stress-induced oxidative status in rat brain. Neuropsychopharmacology 28:1579–1588

    Article  CAS  PubMed  Google Scholar 

  • Mangialasche F, Polidori MC, Monastero R, Ercolani S, Camarda C, Cecchetti R et al (2009) Biomarkers of oxidative and nitrosative damage in Alzheimer’s disease and mild cognitive impairment. Aging Res Rev 8:285–305

    Article  CAS  Google Scholar 

  • Mao P (2012) Oxidative stress and its clinical applications in dementia. J Neurodegener Dis 1–15

  • Mao P, Reddy PH (2011) Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer’s disease: implications for early intervention and therapeutics. Biochim Biophys Acta 1812:1359–1370

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Matsumoto Y, Yamaguchi T, Watanabe S, Yamamoto T (2004) Involvement of arachidonic acid cascade in working memory impairment induced by interleukin-1 beta. Neuropharmacology 46:1195–1200

    Article  CAS  PubMed  Google Scholar 

  • Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L et al (2006) Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern. Neuroscience 141:1149–1162

    Article  CAS  PubMed  Google Scholar 

  • Miranda MI, Ferreira G, Ramirez-Lugo L, Bermudez-Rattoni F (2003) Role of cholinergic system on the construction of memories: taste memory encoding. Neurobiol Learn Mem 80:211–222

    Article  CAS  PubMed  Google Scholar 

  • Montine TJ, Sidell KR, Crews BC, Markesbery WR, Marnett LJ, Roberts LJ (1999) Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology 53:1495–1498

    Article  CAS  PubMed  Google Scholar 

  • Morris RGM (1984) Development of a water-maze procedure for studying spatial learning in the rats. J Neurosci Methods 11:47–60

    Article  CAS  PubMed  Google Scholar 

  • O’Banion MK (1999) COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration. Expert Opin Investig Drugs 8:1521–1536

    Article  PubMed  Google Scholar 

  • Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain. Neuroscience 87:319–324

    Article  CAS  PubMed  Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, San Diego

    Google Scholar 

  • Pepicelli O, Fedele E, Bonanno G, Raiteri M, Ajmone-Cat MA, Greco A et al (2002) In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E-2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J Neurochem 81:1028–1034

    Article  CAS  PubMed  Google Scholar 

  • Popic P, Nalepa I, Mamczarz J, Vetulani J (1994) Retrieval associated cholinergic activity and its inhibition by memory updating. Life Sci 54:1251–1257

    Article  Google Scholar 

  • Pratico D (2002) Alzheimer’s disease and oxygen radicals: new insights. Biochem Pharmacol 63:563–567

    Article  CAS  PubMed  Google Scholar 

  • Pratico D (2008) Evidence of oxidative stress in Alzheimer’s disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:70–78

    Article  CAS  PubMed  Google Scholar 

  • Pratico D, Zhukareva V, Yao Y, Uryu K, Funk CD, Lawson JA et al (2004) 12/15-Lipoxygenase is increased in Alzheimer’s disease: possible involvement in brain oxidative stress. Am J Pathol 164:1655–1662

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rai S, Kamat PK, Nath C, Shukla R (2012) A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254(1–2):1–9

    PubMed  Google Scholar 

  • Salkovic-Petrisic M (2008) Amyloid cascade hypothesis: is it true for sporadic Alzheimer’s disease. Period Biologrum 110:17–25

    CAS  Google Scholar 

  • Salkovic-Petrisic M, Hoyer S (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm 72:217–233

    Article  CAS  Google Scholar 

  • Sarter M, Parikh V (2005) Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6:48–56

    Article  CAS  PubMed  Google Scholar 

  • Shaftel SS, Kyrkanides S, Olschowka JA, Miller JH, Johnson RE, O’Banion MK (2007) Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J Clin Invest 117:1595–1604

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Shaftel SS, Griffin WST, O’Banion MK (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation 5:1–12

    Article  Google Scholar 

  • Sharma N, Deshmukh R, Bedi KL (2010) SP600125, a competitive inhibitor of JNK attenuates streptozotocin induced neurocognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 96:386–394

    Article  CAS  PubMed  Google Scholar 

  • Sharma V, Bala A, Deshmukh R, Bedi KL, Sharma PL (2012) Neuroprotective effect of RO-20-1724-a phosphodiesterase4 inhibitor against intracerebroventricular streptozotocin induced cognitive deficit and oxidative stress in rats. Pharmacol Biochem Behav 101:239–245

    Article  CAS  PubMed  Google Scholar 

  • Shoham S, Bejar C, Kovalev E, Schorer-Apelbaum D, Weinstock M (2007) Ladostigil prevents gliosis, oxidative–nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats. Neuropharmacology 52:836–843

    Article  CAS  PubMed  Google Scholar 

  • Singh VP, Patil CS, Kulkarni SK (2006) Anti-inflammatory effect of licofelone against various inflammatory challenges. Fundam Clin Pharmacol 20:65–71

    Article  CAS  PubMed  Google Scholar 

  • Smith WL, DeWitt DL, Garavito RM (2000) Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 69:145–182

    Article  CAS  PubMed  Google Scholar 

  • Song MS, Rauw G, Baker GB, Kar S (2008) Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation. Eur J Neurosci 28:1989–2002

    Article  CAS  PubMed  Google Scholar 

  • Sonkusare S, Srinivasan K, Kaul C, Ramarao P (2005) Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats. Life Sci 77:1–14

    Article  CAS  PubMed  Google Scholar 

  • Tahirovic I, Sofic E, Sapcanin A (2007) Reduced brain antioxidant capacity in rat models of betacytotoxic-induced impairment induced by interleukin-1 beta. Neuropharmacology 46:1195–1200

    Google Scholar 

  • Tang SS, Wang XY, Hong H, Long Y, Li YQ, Xiang GQ et al (2013) Leukotriene D4 induces cognitive impairment through enhancement of CysLT1 R-mediated amyloid-β generation in mice. Neuropharmacology 65:182–192

    Article  CAS  PubMed  Google Scholar 

  • Tuppo EE, Arias HR (2005) The role of inflammation in Alzheimer’s disease. Int J Biochem Cell Biol 37:289–305

    Article  CAS  PubMed  Google Scholar 

  • Wang XL, Su B, Zheng L, Perry G, Smith MA, Zhu XW (2009) The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease. J Neurochem 109:153–159

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Wang XY, Tang SS, Hu M, Long Y, Li YQ, Liao MX et al (2013) Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. Neurochem Int 62:340–347

    Article  CAS  PubMed  Google Scholar 

  • Wickens AP (2001) Ageing and the free radical theory. Respir Physiol 28:379–391

    Article  Google Scholar 

  • Wills ED (1996) Mechanism of lipid peroxide formation in animal. Biochem J 99:667–676

    Google Scholar 

  • Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 12:1005–1015

    CAS  PubMed  Google Scholar 

  • Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L et al (2002) Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer’s disease neuropathology. Neurobiol Aging 23(3):327–334

    Article  CAS  PubMed  Google Scholar 

  • Yao Y, Clark CM, Trojanowski JQ, Lee VM, Pratico D (2005) Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment. Ann Neurol 58:623–626

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors are thankful to Mr. Parveeen Garg, Chairman, ISF College of Pharmacy, Moga (Punjab), for his praiseworthy inspiration and financial support for this study.

Author information

Authors and Affiliations

  1. Neuropharmacology Division, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, 142001, India

    Ashok Kumar, Sorabh Sharma, Ashwani Prashar & Rahul Deshmukh

Authors
  1. Ashok Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sorabh Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ashwani Prashar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rahul Deshmukh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rahul Deshmukh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumar, A., Sharma, S., Prashar, A. et al. Effect of Licofelone—A Dual COX/5-LOX Inhibitor in Intracerebroventricular Streptozotocin-Induced Behavioral and Biochemical Abnormalities in Rats. J Mol Neurosci 55, 749–759 (2015). https://doi.org/10.1007/s12031-014-0414-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-014-0414-4

Keywords

Search

Navigation